Update
$Ocular Therapeutix(OCUL.US$ Ocular Therapeutix - 46.2% of Patients Showed a 1- or 2-Step Improvement in Diabetic Retinopathy Severity Scale (Drss) at 40 Weeks in Axpaxli Arm
Ocular Therapeutix Inc - No Patients in Axpaxli Group Experienced Worsening in Drss Compared to 12.5% in Control Arm at 40 Weeks
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
